Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 1,037 | 1,006 | 326 | 760 | 463 |
| Gross Profit | 1,037 | 1,006 | 326 | 760 | 463 |
| Operating Expenses | 30,981 | 27,799 | 19,172 | 12,980 | 9,026 |
| Operating Income | -29,944 | -26,793 | -18,846 | -12,220 | -8,563 |
| Interest Expense | 0 | 13 | 190 | 658 | 637 |
| Other Income | 26 | -527 | 37 | -1,067 | -8 |
| Pre-tax Income | -29,918 | -27,333 | -18,999 | -13,945 | -9,208 |
| Net Income Continuous | -29,918 | -27,333 | -18,999 | -13,945 | -9,208 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 585 |
| Net Income | $-29,918 | $-27,333 | $-18,999 | $-13,945 | $-8,623 |
| EPS Basic Total Ops | -0.02 | -0.70 | -0.49 | -1.67 | -4.74 |
| EPS Basic Continuous Ops | -0.01 | -0.70 | -0.49 | -1.67 | -5.57 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.82 |
| EPS Diluted Total Ops | -0.02 | -0.70 | -0.49 | -1.67 | -4.74 |
| EPS Diluted Continuous Ops | -0.01 | -0.70 | -0.49 | -1.67 | -5.57 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.82 |
| EPS Diluted Before Non-Recurring Items | -0.77 | -0.70 | -0.49 | N/A | N/A |
| EBITDA(a) | $-29,859 | $-26,715 | $-18,790 | $-12,181 | $-8,533 |